Stay updated on SPN-812 Classroom Study in Children With ADHD Clinical Trial
Sign up to get notified when there's something new on the SPN-812 Classroom Study in Children With ADHD Clinical Trial page.

Latest updates to the SPN-812 Classroom Study in Children With ADHD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedSignificant changes: added a government operating-status notice and updated version to v3.2.0; removed the previous version reference v3.1.0.”} } } } cannot parse HTTP } }} (Note: The trailing characters are unintended.) } }}SummaryDifference4%

- Check35 days agoChange DetectedThe page now announces Revision: v3.1.0 and removes several drug-safety related topics, indicating content reorganization and scope narrowing.SummaryDifference0.5%

- Check49 days agoChange DetectedThe page now shows Revision: v3.0.2, indicating a new release. The 'Back to Top' link was removed as a minor UI change.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and drug information for Viloxazine Hydrochloride, while previous location details and an older revision number have been removed.SummaryDifference3%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to SPN-812 Classroom Study in Children With ADHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPN-812 Classroom Study in Children With ADHD Clinical Trial page.